{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:35:43Z","timestamp":1778895343560,"version":"3.51.4"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":775,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Avtal om l\u00e4karutbildning och forskning"},{"name":"Janssen-Cilag AB"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Patients with heart failure (HF) exhibit poor prognosis, which is further deteriorated by pulmonary hypertension (PH), with negative impact on morbidity and mortality. As PH due to left HF (LHF-PH) is among the most common causes of PH, there is an urge according to the 2021 European Society of Cardiology HF guidelines to find new biomarkers that aid in prognostication of this patient cohort. Given the role of tumour necrosis factor-alpha (TNF-\u03b1) in HF progression, we aimed to investigate the prognostic value of plasma proteins related to TNF-\u03b1 in patients with LHF-PH, in relation to haemodynamic changes following heart transplantation (HT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Twenty TNF-\u03b1-related plasma proteins were analysed using proximity extension assay in healthy controls (n = 20) and patients with LHF-PH (n = 67), before and 1 year after HT (n = 19). Plasma levels were compared between the groups, and the prognostic values were determined using Kaplan\u2013Meier and Cox regression analyses. Plasma levels of lymphotoxin-beta receptor (LTBR), TNF receptor superfamily member 6B (TNFRSF6B), and TNF-related apoptosis-inducing ligand receptors 1 and 2 (TRAIL-R1 and TRAIL-R2, respectively) were higher in LHF-PH pre-HT vs. controls (P &amp;lt; 0.0001), as well as higher in pre-HT vs. post-HT (P &amp;lt; 0.001). The elevated pre-HT levels of LTBR, TNFRSF6B, TRAIL-R1, and TRAIL-R2 decreased towards the levels of healthy controls after HT. Higher preoperative levels of LTBR, TNFRSF6B, TRAIL-R1, and TRAIL-R2 in LHF-PH were associated with worse survival rates (P &amp;lt; 0.002). In multivariate Cox regression models, each adjusted for age and sex, LTBR, TNFRSF6B, TRAIL-R1, and TRAIL-R2 predicted mortality (P &amp;lt; 0.002) [hazard ratio (95% confidence interval): 1.12 (1.04\u20131.19), 1.01 (1.004\u20131.02), 1.28 (1.14\u20131.42), and 1.03 (1.02\u20131.04), respectively].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated pre-HT plasma levels of the TNF-\u03b1-related proteins LTBR, TNFRSF6B, TRAIL-R1, and TRAIL-R2 in LHF-PH decreased 1 year after HT, displaying a normalization pattern towards the levels of the healthy controls. These proteins were also prognostic, where higher levels were associated with worse survival rates in LHF-PH, providing new insight in their potential role as prognostic biomarkers. Larger studies are warranted to validate our findings and to investigate their possible pathobiological mechanisms in LHF-PH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14507","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T04:50:16Z","timestamp":1695963016000},"page":"3582-3591","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Plasma Tumour Necrosis Factor-Alpha-Related Proteins in Prognosis of Heart Failure with Pulmonary Hypertension"],"prefix":"10.1093","volume":"10","author":[{"given":"Adam","family":"Engel S\u00e4llberg","sequence":"first","affiliation":[{"name":"The Section for Cardiology, Department of Clinical Sciences Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"The Haemodynamic Lab, The Section for Heart Failure and Valvular Disease, VO Heart and Lung Medicine, Sk\u00e5ne University Hospital , Lund ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Helleberg","sequence":"additional","affiliation":[{"name":"The Section for Cardiology, Department of Clinical Sciences Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"The Haemodynamic Lab, The Section for Heart Failure and Valvular Disease, VO Heart and Lung Medicine, Sk\u00e5ne University Hospital , Lund ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salaheldin","family":"Ahmed","sequence":"additional","affiliation":[{"name":"The Section for Cardiology, Department of Clinical Sciences Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"The Haemodynamic Lab, The Section for Heart Failure and Valvular Disease, VO Heart and Lung Medicine, Sk\u00e5ne University Hospital , Lund ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulla","family":"Ahmed","sequence":"additional","affiliation":[{"name":"The Section for Cardiology, Department of Clinical Sciences Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"The Haemodynamic Lab, The Section for Heart Failure and Valvular Disease, VO Heart and Lung Medicine, Sk\u00e5ne University Hospital , Lund ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran","family":"R\u00e5degran","sequence":"additional","affiliation":[{"name":"The Section for Cardiology, Department of Clinical Sciences Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"The Haemodynamic Lab, The Section for Heart Failure and Valvular Disease, VO Heart and Lung Medicine, Sk\u00e5ne University Hospital , Lund ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"2026012113205096500_ehf214507-bib-0001","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2012.10.002","article-title":"Heart failure","volume":"1","author":"Braunwald","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2026012113205096500_ehf214507-bib-0002","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012113205096500_ehf214507-bib-0003","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2026012113205096500_ehf214507-bib-0004","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/CIRCRESAHA.118.312706","article-title":"Established and emerging roles of biomarkers in heart failure","volume":"123","author":"Ibrahim","year":"2018","journal-title":"Circ Res"},{"key":"2026012113205096500_ehf214507-bib-0005","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10557-020-07071-0","article-title":"Inflammatory cytokines and chemokines as therapeutic targets in heart failure","volume":"34","author":"Hanna","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026012113205096500_ehf214507-bib-0006","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1161\/CIRCULATIONAHA.107.759191","article-title":"Tumor necrosis factor-alpha and mortality in heart failure: A community study","volume":"118","author":"Dunlay","year":"2008","journal-title":"Circulation"},{"key":"2026012113205096500_ehf214507-bib-0007","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1172\/JCI115873","article-title":"Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs","volume":"90","author":"Pagani","year":"1992","journal-title":"J Clin Invest"},{"key":"2026012113205096500_ehf214507-bib-0008","doi-asserted-by":"publisher","first-page":"H960","DOI":"10.1152\/ajpheart.0718.2001","article-title":"Morphological and functional changes in cardiac","volume":"284","author":"Janczewski","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026012113205096500_ehf214507-bib-0009","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1161\/01.CIR.97.14.1375","article-title":"Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-\u03b1","volume":"97","author":"Bryant","year":"1998","journal-title":"Circulation"},{"key":"2026012113205096500_ehf214507-bib-0010","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1161\/01.CIR.93.4.704","article-title":"Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart","volume":"93","author":"Torre-Amione","year":"1996","journal-title":"Circulation"},{"key":"2026012113205096500_ehf214507-bib-0011","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/01.CIR.0000155614.35441.69","article-title":"Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study","volume":"111","author":"Valgimigli","year":"2005","journal-title":"Circulation"},{"key":"2026012113205096500_ehf214507-bib-0012","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1161\/01.CIR.102.25.3060","article-title":"Plasma cytokine parameters and mortality in patients with chronic heart failure","volume":"102","author":"Rauchhaus","year":"2000","journal-title":"Circulation"},{"key":"2026012113205096500_ehf214507-bib-0013","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the role of inflammation in heart failure","volume":"17","author":"Adamo","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2026012113205096500_ehf214507-bib-0014","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1079142","article-title":"Pathogenesis of pulmonary hypertension caused by left heart disease","volume":"10","author":"Xiao","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026012113205096500_ehf214507-bib-0015","first-page":"61","article-title":"Importance of tumor necrosis factor-alpha in the pathogenesis of heart failure","volume":"55","author":"Heberto Herrera Garza","year":"2002","journal-title":"Rev Esp Cardiol"},{"key":"2026012113205096500_ehf214507-bib-0016","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/387184","article-title":"Meta-analysis of cytokine gene polymorphisms and outcome of heart transplantation","volume":"2013","author":"Yongcharoen","year":"2013","journal-title":"Biomed Res Int"},{"key":"2026012113205096500_ehf214507-bib-0017","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1053\/euhj.1998.1478","article-title":"The TNF-alpha system in heart failure and after heart transplantation: Plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity","volume":"20","author":"Van Riemsdijk-van Overbeeke","year":"1999","journal-title":"Eur Heart J"},{"key":"2026012113205096500_ehf214507-bib-0018","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.trim.2008.01.001","article-title":"TNF\u03b1 in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device","volume":"19","author":"Bruggink","year":"2008","journal-title":"Transpl Immunol"},{"key":"2026012113205096500_ehf214507-bib-0019","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.570016","article-title":"Current understanding of circulating biomarkers in pulmonary hypertension due to left heart disease","volume":"7","author":"Todd","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"2026012113205096500_ehf214507-bib-0020","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01897-2018","article-title":"Pulmonary hypertension due to left heart disease","volume":"53","author":"Vachiery","year":"2019","journal-title":"Eur Respir J"},{"key":"2026012113205096500_ehf214507-bib-0021","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS ONE"},{"key":"2026012113205096500_ehf214507-bib-0022","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012113205096500_ehf214507-bib-0023","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/archinte.1916.00080130010002","article-title":"Clinical calorimetry: Tenth paper a formula to estimate the approximate surface area if height and weight be known","volume":"XVII","author":"Du Bois","year":"1916","journal-title":"Arch Intern Med"},{"key":"2026012113205096500_ehf214507-bib-0024","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1515\/cclm-2013-0741","article-title":"The revised Lund-Malmo GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population","volume":"52","author":"Nyman","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"2026012113205096500_ehf214507-bib-0025","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.healun.2006.06.008","article-title":"Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates\u20142006","volume":"25","author":"Mehra","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"2026012113205096500_ehf214507-bib-0026","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2026012113205096500_ehf214507-bib-0027","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"2026012113205096500_ehf214507-bib-0028","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026012113205096500_ehf214507-bib-0029","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012113205096500_ehf214507-bib-0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2022.100190","article-title":"Higher plasma IL-6 and PTX3 are associated with worse survival in left heart failure with pulmonary hypertension","volume":"20","author":"Helleberg","year":"2022","journal-title":"Am Heart J Plus: Cardiol Res Pract"},{"key":"2026012113205096500_ehf214507-bib-0031","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1107\/S2053230X15016416","article-title":"The structure of the death receptor 4-TNF-related apoptosis-inducing ligand (DR4-TRAIL) complex","volume":"71","author":"Ramamurthy","year":"2015","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"2026012113205096500_ehf214507-bib-0032","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"2026012113205096500_ehf214507-bib-0033","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1536\/jhj.44.833","article-title":"Enhanced expression of the apoptosis inducing ligand TRAIL in mononuclear cells after myocardial infarction","volume":"44","author":"Hitoshi Nakajima","year":"2003","journal-title":"Jpn Heart J"},{"key":"2026012113205096500_ehf214507-bib-0034","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10061252","article-title":"TRAIL and cardiovascular disease\u2014A risk factor or risk marker: A systematic review","volume":"10","author":"Kakareko","year":"2021","journal-title":"J Clin Med"},{"key":"2026012113205096500_ehf214507-bib-0035","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s10637-010-9627-8","article-title":"TRAIL shows potential cardioprotective activity","volume":"30","author":"Toffoli","year":"2012","journal-title":"Invest New Drugs"},{"key":"2026012113205096500_ehf214507-bib-0036","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/eurheartj\/ehp004","article-title":"Prognostic value of apoptosis markers in advanced heart failure patients","volume":"30","author":"Niessner","year":"2009","journal-title":"Eur Heart J"},{"key":"2026012113205096500_ehf214507-bib-0037","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM199610173351603","article-title":"Apoptosis in myocytes in end-stage heart failure","volume":"335","author":"Narula","year":"1996","journal-title":"N Engl J Med"},{"key":"2026012113205096500_ehf214507-bib-0038","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJM199704173361603","article-title":"Apoptosis in the failing human heart","volume":"336","author":"Olivetti","year":"1997","journal-title":"N Engl J Med"},{"key":"2026012113205096500_ehf214507-bib-0039","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bcp.2011.01.011","article-title":"Decoy receptor 3: A pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer","volume":"81","author":"Lin","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"2026012113205096500_ehf214507-bib-0040","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.120.045810","article-title":"Proteomic evaluation of the comorbidity-inflammation paradigm in heart failure with preserved ejection fraction: Results from the PROMIS-HFpEF study","volume":"142","author":"Sanders-van Wijk","year":"2020","journal-title":"Circulation"},{"key":"2026012113205096500_ehf214507-bib-0041","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jchf.2017.04.007","article-title":"Biomarker profiles of acute heart failure patients with a mid-range ejection fraction","volume":"5","author":"Tromp","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026012113205096500_ehf214507-bib-0042","doi-asserted-by":"publisher","first-page":"13733","DOI":"10.1074\/jbc.274.20.13733","article-title":"A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis","volume":"274","author":"Yu","year":"1999","journal-title":"J Biol Chem"},{"key":"2026012113205096500_ehf214507-bib-0043","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1189\/jlb.0903448","article-title":"Modulation of macrophage differentiation and activation by decoy receptor 3","volume":"75","author":"Chang","year":"2004","journal-title":"J Leukoc Biol"},{"key":"2026012113205096500_ehf214507-bib-0044","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.4049\/jimmunol.168.10.4846","article-title":"Modulation of dendritic cell differentiation and maturation by decoy receptor 3","volume":"168","author":"Hsu","year":"2002","journal-title":"J Immunol"},{"key":"2026012113205096500_ehf214507-bib-0045","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1164\/rccm.200902-0222OC","article-title":"Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndrome","volume":"180","author":"Chen","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012113205096500_ehf214507-bib-0046","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/gut.2008.148908","article-title":"Functional characterisation of decoy receptor 3 in Crohn's disease","volume":"58","author":"Funke","year":"2009","journal-title":"Gut"},{"key":"2026012113205096500_ehf214507-bib-0047","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.3892\/etm.2019.7222","article-title":"Decoy receptor-3 regulates inflammation and apoptosis via PI3K\/AKT signaling pathway in coronary heart disease","volume":"17","author":"Chen","year":"2019","journal-title":"Exp Ther Med"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/6\/3582\/64699452\/eschf_10_6_3582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/6\/3582\/64699452\/eschf_10_6_3582.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:25:14Z","timestamp":1769019914000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/10\/6\/3582\/8284363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,9,29]]},"published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14507","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,9,29]]},"assertion":[{"value":"2023-02-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}